AnodyneWiki

Carbidopa

Carbidopa
Carbidopa
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass226.23 g/mol [1]
Melting point203-208 °C [1]
Boiling pointDecomposes [1]
Solubility3.8 mg/L [1]
Predicted LogP-2.2 [1]
Structural Identifiers
[]
Molecular formulaC10H14N2O4
IUPAC name(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
SMILESC[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN
InChIInChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1
InChIKeyTZFNLOMSOLWIDK-JTQLQIEISA-N
CAS number28860-95-9
UNIIKR87B45RGH
PubChem CID34359
Pharmacokinetics[]
Elimination half-life2 hours
Metabolism7 metabolites known, not metabolized extensively

Carbidopa (also known as Lodosyn, Carbidopa anhydrous, N-Aminomethyldopa, (S)-(-)-carbidopa, α-Methyldopahydrazine, Carbidopum, L-α-Methyldopahydrazine, Carbidopa (anhydrous), (S)-carbidopa or Mk 486) is a substance of the phentermine, amino acid and catecholamine class.

Chemistry

 []

Carbidopa is a single defined stereoisomer (optical activity ( - )).

Carbidopa matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Carbidopa is an inhibitor of the DDC which in order, inhibits the peripheral metabolism of levodopa. DDC is very important in the biosynthesis of L-tryptophan to serotonin and the modification of L-DOPA to dopamine. DDC can be found in the body periphery and in the blood-brain barrier. The action of carbidopa is focused on peripheral DDC as this drug cannot cross the blood-brain barrier. Hence, it will prevent the metabolism of [levodopa] in the periphery but it will not have any activity on the generation of dopamine in the brain. [1]

Medical side effects []

126 side effects listed on drug labels in (carbidopa).

  • Dyskinesia
  • Movements involuntary
  • Nausea
  • Hallucination
  • Confusional state
  • Feeling abnormal
  • Malaise
  • Dizziness
  • Syncope
  • Urinary tract infection
  • Headache
  • Vomiting
  • Depression
  • Upper respiratory tract infection
  • Dry mouth
  • Decreased appetite
  • Back pain
  • Insomnia
  • Orthostatic hypotension
  • Dyspnoea
  • Paraesthesia
  • Pollakiuria
  • Chest pain
  • Diarrhoea
  • Muscle spasms
  • Constipation
  • Dyspepsia
  • Heartburn
  • Musculoskeletal pain
  • Abdominal pain
  • Gastrointestinal pain
  • Agranulocytosis
  • Alopecia
  • Anaemia
  • Haemolytic anaemia
  • Angioedema
  • Anxiety
  • Asthenia
  • Fatigue
  • Ataxia
  • Blepharospasm
  • Blister
  • Dermatitis bullous
  • Bruxism
  • Chorea
  • Choreiform
  • Nasopharyngitis
  • Rhinitis
  • Cough
  • Dysphagia
  • Delusion
  • Diplopia
  • Duodenal ulcer
  • Oedema
  • Dermatitis
  • Rash
  • Extrapyramidal disorder
  • Flatulence
  • Flushing
  • Gastrointestinal haemorrhage
  • Hiccups
  • Dysphonia
  • Horner's syndrome
  • Hypersensitivity
  • Hypertension
  • Hypotension
  • Libido increased
  • Disturbance in sexual arousal
  • Pain in extremity
  • Leukopenia
  • Malignant melanoma
  • Mydriasis
  • Myocardial infarction
  • Acute coronary syndrome
  • Nervousness
  • Tension
  • Neuroleptic malignant syndrome
  • Nightmare
  • Hypoaesthesia
  • Sensory loss
  • Pain
  • Palpitations
  • Pathological gambling
  • Pemphigus
  • Neuropathy peripheral
  • Phlebitis
  • Priapism
  • Pruritus
  • Henoch-Schonlein purpura
  • Convulsion
  • Salivary hypersecretion
  • Shock
  • Loss of consciousness
  • Thrombocytopenia
  • Tremor
  • Trismus
  • Urinary incontinence
  • Urticaria
  • Weight increased
  • Weight decreased
  • Urinary retention
  • Agitation
  • Oculogyric crisis
  • Blood urea increased
  • Haemoglobin decreased
  • Depression suicidal
  • Discomfort
  • Ill-defined disorder
  • Emotional distress
  • Muscle twitching
  • Disorientation
  • Memory impairment
  • Euphoric mood
  • Glossodynia
  • Hypersexuality
  • Psychotic disorder
  • Vision blurred
  • Dementia
  • Gait disturbance
  • Menopausal symptoms
  • Hot flush
  • Blood creatinine increased
  • Hyperhidrosis
  • White blood cell count decreased
  • Sleep disorder
  • Somnolence

Indications

  • Intoxication
  • Nausea
  • Parkinson's disease
  • Parkinsonism
  • Parkinsonism post encephalitic
  • Secondary parkinsonism
  • Vomiting

Experience reports

Erowid

There are currently 2 experience reports involving carbidopa on : []

 []

  • United Kingdom: Carbidopa is Prescription only.
  • United States: Carbidopa is Prescription only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 34359, Carbidopa. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/34359
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Carbidopa. UNII: KR87B45RGH. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/KR87B45RGH

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 07:06:39
drugspromissing (no DrugsPRO reagent data)2026-11-20 07:06:35
erowidok2026-11-20 07:06:38
gsrsok2026-11-20 07:06:35
hmdbmissing (hmdb.ca refused automated access to HMDB0014336)2026-11-20 07:06:35
keggok2026-11-20 07:06:37
pubchemok2026-11-20 07:06:35
redditmissing (no r/tripreports posts mention it)2026-11-20 07:06:35
siderok2026-11-20 07:06:35
structureok2026-11-20 07:06:35
wikipediaok2026-11-20 07:06:35